Clinical concerns of immunogenicity produced at cellular levels by biopharmaceuticals following their parenteral administration into human body

Author： Tamilvanan Shunmugaperumal Raja Natarajan Livingston Sa Biswanath Basu Sanat Kumar

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.18, Iss.7, 2010-08, pp. : 489-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical findings and gingival crevicular fluid prostaglandin E2 and interleukin-1-beta levels following initial periodontal treatment and short-term meloxicam administration

By Buduneli Nurcan Buduneli Eralp Çetin Emel Öykü Kırılmaz Levent Kütükçüler Necil

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1805-1812

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of cyclizine following intravenous administration to human volunteers

By Walker R.B. Kanfer I.

European Journal of Pharmaceutical Sciences, Vol. 4, Iss. 5, 1996-09 ,pp. : 301-306

Elsevier

Access to resources Recommend Favorite

A Review of Human Phase 0 (Microdosing) Clinical Trials Following the US Food and Drug Administration Exploratory Investigational New Drug Studies Guidance

By Lappin Graham Garner R. Colin

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 3, 2006-01 ,pp. : 159-165

Adis International

Access to resources Recommend Favorite

Immunotherapies: Foreign body granulomatous reaction following intradermal administration: case report

Reactions Weekly, Vol. 1, Iss. 1080, 2005-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Levels of dopamine in blood and brain following nasal administration to rats

By Dahlin M. Jansson B. Bjork E.

European Journal of Pharmaceutical Sciences, Vol. 14, Iss. 1, 2001-08 ,pp. : 75-80

Elsevier

Access to resources Recommend Favorite